Affordable Diagnostics PAI Life Sciences has been involved in developing an affordable six-minute COVID-19 diagnostic test for use in low-resource settings, indicating a clear opportunity to partner on manufacturing, distribution, regulatory strategy, and scale-up for rapid diagnostics in global health markets.

Translational Expertise The company specializes in developmental and translational research to move products from the laboratory to bedside, presenting avenues for collaboration on preclinical and clinical development, protein therapeutics optimization, and manufacturing process development for vaccines and biologics.

Underserved Focus With a mission to address neglected diseases, there are potential sales opportunities with global health NGOs, government programs, and grant-funded initiatives seeking collaborations on diagnostics, vaccines, or therapeutics tailored to underserved populations.

nimble Partnerships As a small team (2-10 employees) that already collaborates with external partners, PAI Life Sciences appears well-suited for project-based partnerships with larger CROs, biotech firms, or pharma companies for early-stage development and outsourcing needs.

Diverse Pipeline The pipeline covering infectious disease vaccines and adjuvants as well as cancer therapeutics presents multiple licensing or co-development opportunities with multinational companies looking to broaden their biologics portfolio and address growing demand in vaccines and oncology.